Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium

The oropharyngeal mucosa serves as a perpetual pathogen entry point and a critical site for viral replication and spread. Here, we demonstrate that type 1 innate lymphoid cells (ILC1s) were the major immune force providing early protection during acute oral mucosal viral infection. Using intravital...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunity (Cambridge, Mass.) Mass.), 2021-02, Vol.54 (2), p.276-290.e5
Hauptverfasser: Shannon, John P., Vrba, Sophia M., Reynoso, Glennys V., Wynne-Jones, Erica, Kamenyeva, Olena, Malo, Courtney S., Cherry, Christian R., McManus, Daniel T., Hickman, Heather D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 290.e5
container_issue 2
container_start_page 276
container_title Immunity (Cambridge, Mass.)
container_volume 54
creator Shannon, John P.
Vrba, Sophia M.
Reynoso, Glennys V.
Wynne-Jones, Erica
Kamenyeva, Olena
Malo, Courtney S.
Cherry, Christian R.
McManus, Daniel T.
Hickman, Heather D.
description The oropharyngeal mucosa serves as a perpetual pathogen entry point and a critical site for viral replication and spread. Here, we demonstrate that type 1 innate lymphoid cells (ILC1s) were the major immune force providing early protection during acute oral mucosal viral infection. Using intravital microscopy, we show that ILC1s populated and patrolled the uninfected labial mucosa. ILC1s produced interferon-γ (IFN-γ) in the absence of infection, leading to the upregulation of key antiviral genes, which were downregulated in uninfected animals upon genetic ablation of ILC1s or antibody-based neutralization of IFN-γ. Thus, tonic IFN-γ production generates increased oral mucosal viral resistance even before infection. Our results demonstrate barrier-tissue protection through tissue surveillance in the absence of rearranged-antigen receptors and the induction of an antiviral state during homeostasis. This aspect of ILC1 biology raises the possibility that these cells do not share true functional redundancy with other tissue-resident lymphocytes. [Display omitted] •Oral mucosa ILC1s restrict viral replication in the epithelium•ILC1s patrol the basal layers of the oral epithelium at steady state•ILC1s produce tonic IFN-γ, upregulating antiviral genes in the epithelium•ILC1s prime uninfected tissue to restrict viral replication ILC1s provide antiviral protection at initial sites of viral encounter, but how these cells accomplish this spatially in the tissue remains unexplored. Shannon et al. show that ILC1s patrol the uninfected epithelium of the oral mucosa and provide protection even before infection through the production of IFN-γ.
doi_str_mv 10.1016/j.immuni.2020.12.004
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7881522</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S107476132030532X</els_id><sourcerecordid>2487973951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-e7b3053a0acaeff2853143a1ea79079c23b4ad6c46666dd9867fe024f55dc2513</originalsourceid><addsrcrecordid>eNp9UcuO1DAQtBCIfcAfIBSJC5cMfiVOLkhoBbtIK3GBs-WxOzs9xHawk0j7XfsffBMeZlkeByxZdruq29VdhLxgdMMoa9_sN-j9EnDDKS9PfEOpfEROGe1VLVlHHx_uStaqZeKEnOW8p5TJpqdPyYkQUkjZy1Py9TLFZapYhSGYGarx1k-7iK62MI61g4QruALOkAZIMdTf7ypvSlx2rkyYsV4xmbFa8QZHEywUcjXvoPKLjbkAMGEJR1z8M_JkMGOG5_fnOfny4f3ni6v6-tPlx4t317WVPZtrUFtBG2GosQaGgXeNYFIYBkb1VPWWi600rrWyLcu5vmvVAJTLoWmc5Q0T5-Ttse60bD04C2EuCvWU0Jt0q6NB_TcScKdv4qpV17GG81Lg9X2BFL8tkGftMR8GYgLEJWsulWoo6zgt1Ff_UPdxSaG0V1id6pXofyqSR5ZNMecEw4MYRvXBTb3XRzf1wU3NuC5ulrSXfzbykPTLvt-dQhnnipB0tgjFBIcJ7KxdxP__8AMACbVm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2487973951</pqid></control><display><type>article</type><title>Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Shannon, John P. ; Vrba, Sophia M. ; Reynoso, Glennys V. ; Wynne-Jones, Erica ; Kamenyeva, Olena ; Malo, Courtney S. ; Cherry, Christian R. ; McManus, Daniel T. ; Hickman, Heather D.</creator><creatorcontrib>Shannon, John P. ; Vrba, Sophia M. ; Reynoso, Glennys V. ; Wynne-Jones, Erica ; Kamenyeva, Olena ; Malo, Courtney S. ; Cherry, Christian R. ; McManus, Daniel T. ; Hickman, Heather D.</creatorcontrib><description>The oropharyngeal mucosa serves as a perpetual pathogen entry point and a critical site for viral replication and spread. Here, we demonstrate that type 1 innate lymphoid cells (ILC1s) were the major immune force providing early protection during acute oral mucosal viral infection. Using intravital microscopy, we show that ILC1s populated and patrolled the uninfected labial mucosa. ILC1s produced interferon-γ (IFN-γ) in the absence of infection, leading to the upregulation of key antiviral genes, which were downregulated in uninfected animals upon genetic ablation of ILC1s or antibody-based neutralization of IFN-γ. Thus, tonic IFN-γ production generates increased oral mucosal viral resistance even before infection. Our results demonstrate barrier-tissue protection through tissue surveillance in the absence of rearranged-antigen receptors and the induction of an antiviral state during homeostasis. This aspect of ILC1 biology raises the possibility that these cells do not share true functional redundancy with other tissue-resident lymphocytes. [Display omitted] •Oral mucosa ILC1s restrict viral replication in the epithelium•ILC1s patrol the basal layers of the oral epithelium at steady state•ILC1s produce tonic IFN-γ, upregulating antiviral genes in the epithelium•ILC1s prime uninfected tissue to restrict viral replication ILC1s provide antiviral protection at initial sites of viral encounter, but how these cells accomplish this spatially in the tissue remains unexplored. Shannon et al. show that ILC1s patrol the uninfected epithelium of the oral mucosa and provide protection even before infection through the production of IFN-γ.</description><identifier>ISSN: 1074-7613</identifier><identifier>EISSN: 1097-4180</identifier><identifier>DOI: 10.1016/j.immuni.2020.12.004</identifier><identifier>PMID: 33434494</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Ablation ; Animals ; Antibodies ; Antigens ; Antiviral agents ; Antiviral state ; Cells, Cultured ; Disease Resistance ; Epithelium ; Homeostasis ; Humans ; Immunity, Innate ; Infections ; innate immunity ; innate lymphoid cell ; Interferon ; Interferon-gamma - genetics ; Interferon-gamma - metabolism ; intravital microscopy ; Lymphocytes ; Lymphocytes - immunology ; Lymphoid cells ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mucosa ; Neutralization ; NK cell ; Oropharynx - immunology ; poxvirus ; Redundancy ; Respiratory Mucosa - immunology ; Rodents ; Smallpox ; T-Box Domain Proteins - genetics ; Th1 Cells - immunology ; Tissues ; Vaccinia - immunology ; Vaccinia virus - physiology ; Vigilance ; viral immunity ; Viral infections ; γ-Interferon</subject><ispartof>Immunity (Cambridge, Mass.), 2021-02, Vol.54 (2), p.276-290.e5</ispartof><rights>2020</rights><rights>Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited Feb 9, 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-e7b3053a0acaeff2853143a1ea79079c23b4ad6c46666dd9867fe024f55dc2513</citedby><cites>FETCH-LOGICAL-c491t-e7b3053a0acaeff2853143a1ea79079c23b4ad6c46666dd9867fe024f55dc2513</cites><orcidid>0000-0002-8722-2209 ; 0000-0003-2661-6981 ; 0000-0001-6796-2202 ; 0000-0003-1679-8240</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S107476132030532X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33434494$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shannon, John P.</creatorcontrib><creatorcontrib>Vrba, Sophia M.</creatorcontrib><creatorcontrib>Reynoso, Glennys V.</creatorcontrib><creatorcontrib>Wynne-Jones, Erica</creatorcontrib><creatorcontrib>Kamenyeva, Olena</creatorcontrib><creatorcontrib>Malo, Courtney S.</creatorcontrib><creatorcontrib>Cherry, Christian R.</creatorcontrib><creatorcontrib>McManus, Daniel T.</creatorcontrib><creatorcontrib>Hickman, Heather D.</creatorcontrib><title>Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium</title><title>Immunity (Cambridge, Mass.)</title><addtitle>Immunity</addtitle><description>The oropharyngeal mucosa serves as a perpetual pathogen entry point and a critical site for viral replication and spread. Here, we demonstrate that type 1 innate lymphoid cells (ILC1s) were the major immune force providing early protection during acute oral mucosal viral infection. Using intravital microscopy, we show that ILC1s populated and patrolled the uninfected labial mucosa. ILC1s produced interferon-γ (IFN-γ) in the absence of infection, leading to the upregulation of key antiviral genes, which were downregulated in uninfected animals upon genetic ablation of ILC1s or antibody-based neutralization of IFN-γ. Thus, tonic IFN-γ production generates increased oral mucosal viral resistance even before infection. Our results demonstrate barrier-tissue protection through tissue surveillance in the absence of rearranged-antigen receptors and the induction of an antiviral state during homeostasis. This aspect of ILC1 biology raises the possibility that these cells do not share true functional redundancy with other tissue-resident lymphocytes. [Display omitted] •Oral mucosa ILC1s restrict viral replication in the epithelium•ILC1s patrol the basal layers of the oral epithelium at steady state•ILC1s produce tonic IFN-γ, upregulating antiviral genes in the epithelium•ILC1s prime uninfected tissue to restrict viral replication ILC1s provide antiviral protection at initial sites of viral encounter, but how these cells accomplish this spatially in the tissue remains unexplored. Shannon et al. show that ILC1s patrol the uninfected epithelium of the oral mucosa and provide protection even before infection through the production of IFN-γ.</description><subject>Ablation</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Antiviral agents</subject><subject>Antiviral state</subject><subject>Cells, Cultured</subject><subject>Disease Resistance</subject><subject>Epithelium</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Immunity, Innate</subject><subject>Infections</subject><subject>innate immunity</subject><subject>innate lymphoid cell</subject><subject>Interferon</subject><subject>Interferon-gamma - genetics</subject><subject>Interferon-gamma - metabolism</subject><subject>intravital microscopy</subject><subject>Lymphocytes</subject><subject>Lymphocytes - immunology</subject><subject>Lymphoid cells</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mucosa</subject><subject>Neutralization</subject><subject>NK cell</subject><subject>Oropharynx - immunology</subject><subject>poxvirus</subject><subject>Redundancy</subject><subject>Respiratory Mucosa - immunology</subject><subject>Rodents</subject><subject>Smallpox</subject><subject>T-Box Domain Proteins - genetics</subject><subject>Th1 Cells - immunology</subject><subject>Tissues</subject><subject>Vaccinia - immunology</subject><subject>Vaccinia virus - physiology</subject><subject>Vigilance</subject><subject>viral immunity</subject><subject>Viral infections</subject><subject>γ-Interferon</subject><issn>1074-7613</issn><issn>1097-4180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcuO1DAQtBCIfcAfIBSJC5cMfiVOLkhoBbtIK3GBs-WxOzs9xHawk0j7XfsffBMeZlkeByxZdruq29VdhLxgdMMoa9_sN-j9EnDDKS9PfEOpfEROGe1VLVlHHx_uStaqZeKEnOW8p5TJpqdPyYkQUkjZy1Py9TLFZapYhSGYGarx1k-7iK62MI61g4QruALOkAZIMdTf7ypvSlx2rkyYsV4xmbFa8QZHEywUcjXvoPKLjbkAMGEJR1z8M_JkMGOG5_fnOfny4f3ni6v6-tPlx4t317WVPZtrUFtBG2GosQaGgXeNYFIYBkb1VPWWi600rrWyLcu5vmvVAJTLoWmc5Q0T5-Ttse60bD04C2EuCvWU0Jt0q6NB_TcScKdv4qpV17GG81Lg9X2BFL8tkGftMR8GYgLEJWsulWoo6zgt1Ff_UPdxSaG0V1id6pXofyqSR5ZNMecEw4MYRvXBTb3XRzf1wU3NuC5ulrSXfzbykPTLvt-dQhnnipB0tgjFBIcJ7KxdxP__8AMACbVm</recordid><startdate>20210209</startdate><enddate>20210209</enddate><creator>Shannon, John P.</creator><creator>Vrba, Sophia M.</creator><creator>Reynoso, Glennys V.</creator><creator>Wynne-Jones, Erica</creator><creator>Kamenyeva, Olena</creator><creator>Malo, Courtney S.</creator><creator>Cherry, Christian R.</creator><creator>McManus, Daniel T.</creator><creator>Hickman, Heather D.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8722-2209</orcidid><orcidid>https://orcid.org/0000-0003-2661-6981</orcidid><orcidid>https://orcid.org/0000-0001-6796-2202</orcidid><orcidid>https://orcid.org/0000-0003-1679-8240</orcidid></search><sort><creationdate>20210209</creationdate><title>Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium</title><author>Shannon, John P. ; Vrba, Sophia M. ; Reynoso, Glennys V. ; Wynne-Jones, Erica ; Kamenyeva, Olena ; Malo, Courtney S. ; Cherry, Christian R. ; McManus, Daniel T. ; Hickman, Heather D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-e7b3053a0acaeff2853143a1ea79079c23b4ad6c46666dd9867fe024f55dc2513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Ablation</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Antiviral agents</topic><topic>Antiviral state</topic><topic>Cells, Cultured</topic><topic>Disease Resistance</topic><topic>Epithelium</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Immunity, Innate</topic><topic>Infections</topic><topic>innate immunity</topic><topic>innate lymphoid cell</topic><topic>Interferon</topic><topic>Interferon-gamma - genetics</topic><topic>Interferon-gamma - metabolism</topic><topic>intravital microscopy</topic><topic>Lymphocytes</topic><topic>Lymphocytes - immunology</topic><topic>Lymphoid cells</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mucosa</topic><topic>Neutralization</topic><topic>NK cell</topic><topic>Oropharynx - immunology</topic><topic>poxvirus</topic><topic>Redundancy</topic><topic>Respiratory Mucosa - immunology</topic><topic>Rodents</topic><topic>Smallpox</topic><topic>T-Box Domain Proteins - genetics</topic><topic>Th1 Cells - immunology</topic><topic>Tissues</topic><topic>Vaccinia - immunology</topic><topic>Vaccinia virus - physiology</topic><topic>Vigilance</topic><topic>viral immunity</topic><topic>Viral infections</topic><topic>γ-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shannon, John P.</creatorcontrib><creatorcontrib>Vrba, Sophia M.</creatorcontrib><creatorcontrib>Reynoso, Glennys V.</creatorcontrib><creatorcontrib>Wynne-Jones, Erica</creatorcontrib><creatorcontrib>Kamenyeva, Olena</creatorcontrib><creatorcontrib>Malo, Courtney S.</creatorcontrib><creatorcontrib>Cherry, Christian R.</creatorcontrib><creatorcontrib>McManus, Daniel T.</creatorcontrib><creatorcontrib>Hickman, Heather D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Immunity (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shannon, John P.</au><au>Vrba, Sophia M.</au><au>Reynoso, Glennys V.</au><au>Wynne-Jones, Erica</au><au>Kamenyeva, Olena</au><au>Malo, Courtney S.</au><au>Cherry, Christian R.</au><au>McManus, Daniel T.</au><au>Hickman, Heather D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium</atitle><jtitle>Immunity (Cambridge, Mass.)</jtitle><addtitle>Immunity</addtitle><date>2021-02-09</date><risdate>2021</risdate><volume>54</volume><issue>2</issue><spage>276</spage><epage>290.e5</epage><pages>276-290.e5</pages><issn>1074-7613</issn><eissn>1097-4180</eissn><abstract>The oropharyngeal mucosa serves as a perpetual pathogen entry point and a critical site for viral replication and spread. Here, we demonstrate that type 1 innate lymphoid cells (ILC1s) were the major immune force providing early protection during acute oral mucosal viral infection. Using intravital microscopy, we show that ILC1s populated and patrolled the uninfected labial mucosa. ILC1s produced interferon-γ (IFN-γ) in the absence of infection, leading to the upregulation of key antiviral genes, which were downregulated in uninfected animals upon genetic ablation of ILC1s or antibody-based neutralization of IFN-γ. Thus, tonic IFN-γ production generates increased oral mucosal viral resistance even before infection. Our results demonstrate barrier-tissue protection through tissue surveillance in the absence of rearranged-antigen receptors and the induction of an antiviral state during homeostasis. This aspect of ILC1 biology raises the possibility that these cells do not share true functional redundancy with other tissue-resident lymphocytes. [Display omitted] •Oral mucosa ILC1s restrict viral replication in the epithelium•ILC1s patrol the basal layers of the oral epithelium at steady state•ILC1s produce tonic IFN-γ, upregulating antiviral genes in the epithelium•ILC1s prime uninfected tissue to restrict viral replication ILC1s provide antiviral protection at initial sites of viral encounter, but how these cells accomplish this spatially in the tissue remains unexplored. Shannon et al. show that ILC1s patrol the uninfected epithelium of the oral mucosa and provide protection even before infection through the production of IFN-γ.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33434494</pmid><doi>10.1016/j.immuni.2020.12.004</doi><orcidid>https://orcid.org/0000-0002-8722-2209</orcidid><orcidid>https://orcid.org/0000-0003-2661-6981</orcidid><orcidid>https://orcid.org/0000-0001-6796-2202</orcidid><orcidid>https://orcid.org/0000-0003-1679-8240</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1074-7613
ispartof Immunity (Cambridge, Mass.), 2021-02, Vol.54 (2), p.276-290.e5
issn 1074-7613
1097-4180
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7881522
source MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Ablation
Animals
Antibodies
Antigens
Antiviral agents
Antiviral state
Cells, Cultured
Disease Resistance
Epithelium
Homeostasis
Humans
Immunity, Innate
Infections
innate immunity
innate lymphoid cell
Interferon
Interferon-gamma - genetics
Interferon-gamma - metabolism
intravital microscopy
Lymphocytes
Lymphocytes - immunology
Lymphoid cells
Mice
Mice, Inbred C57BL
Mice, Knockout
Mucosa
Neutralization
NK cell
Oropharynx - immunology
poxvirus
Redundancy
Respiratory Mucosa - immunology
Rodents
Smallpox
T-Box Domain Proteins - genetics
Th1 Cells - immunology
Tissues
Vaccinia - immunology
Vaccinia virus - physiology
Vigilance
viral immunity
Viral infections
γ-Interferon
title Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A17%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Group%201%20innate%20lymphoid-cell-derived%20interferon-%CE%B3%20maintains%20anti-viral%20vigilance%20in%20the%20mucosal%20epithelium&rft.jtitle=Immunity%20(Cambridge,%20Mass.)&rft.au=Shannon,%20John%20P.&rft.date=2021-02-09&rft.volume=54&rft.issue=2&rft.spage=276&rft.epage=290.e5&rft.pages=276-290.e5&rft.issn=1074-7613&rft.eissn=1097-4180&rft_id=info:doi/10.1016/j.immuni.2020.12.004&rft_dat=%3Cproquest_pubme%3E2487973951%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2487973951&rft_id=info:pmid/33434494&rft_els_id=S107476132030532X&rfr_iscdi=true